Abstract
Refractory epilepsy poses a significant challenge in neurology due to approximately 30% of patients being resistant to conventional pharmacological treatments. This study investigates the efficacy and safety of vagus nerve stimulation (VNS) as a therapeutic alternative for these patients. The primary objective is to analyze the reduction in seizure frequency and improvements in the quality of life of patients treated with VNS. Additionally, the study aims to identify and categorize the side effects associated with the use of VNS. The methodology adopted included a qualitative bibliographic review covering renowned databases such as Scielo, Google Scholar, specialized scientific journals, academic repositories, and virtual libraries. Inclusion criteria considered studies that directly addressed the use of VNS in the treatment of epilepsy, while exclusion criteria eliminated duplicate and methodologically inadequate publications. Results indicate that VNS is effective in reducing seizures and improving quality of life, despite potential side effects. It is concluded that VNS is a viable and cost-effective therapeutic option for patients with refractory epilepsy, highlighting the need for future research to optimize stimulation parameters and minimize adverse effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.